Hospital News
Return to Center for Holistic Urology Overview
More on Center for Holistic Urology
- Bexxar Effective as First-Line Treatment for Non-Hodgkin's Lymphoma Patients When Used With Chemotherapy
- Cancer Treatment Is First to Directly Target Tumor Blood Supply in Patients
- Combination of Abbreviated Chemotherapy with Radioactive Monoclonal Antibody Effective in Previously Untreated Non-Hodgkin's Lymphoma
- Coping With Chronic Cancer Pain
- Do Heart Disease and Cancer Have a Common Genetic Link?
- Health Effects of Secondhand Smoke Studied in First-of-Its-Kind Series of Clinical Studies
- Integrative Therapies Program for Children with Cancer at Morgan Stanley Children's Hospital of NewYork-Presbyterian Receives Gift Commitment from Origins Natural Resources
- Message to the Elderly: It's Never Too Late to Prevent Illness!
- New Book by Weill Cornell Psychiatrist Offers Insight and Hope for "Surviving Cancer Emotionally"
- New Comprehensive Gastrointestinal Health Center To Be Established at NewYork-Presbyterian Weill Cornell
- NewYork-Presbyterian/Weill Cornell Creates World-Class Cancer Center
- NewYork-Presbyterian Hospital's Weill Cornell Medical Center Announces Preliminary Lung Cancer Data Involving Patients Treated With Arthritis Medication
- Popular Arthritic Medication May Prevent Colon Cancer
- Robotic Prostate Surgery Study Finds 5-Year Outcomes Favorable
- Study Looks at New Bladder Cancer Therapy for Patients Unresponsive to Standard Treatment
- The Seventh Issue of Cancer Prevention Has Arrived!
- Tumor Size Predicts Survival in Most Common Type of Lung Cancer
- Two Novel Biologics Studied for Multiple Myeloma
Research and Clinical Trials
Return to Center for Holistic Urology Overview
More on Center for Holistic Urology
Health Library
Return to Center for Holistic Urology Overview
More on Center for Holistic Urology
- Bladder Cancer
- Cancer, Colorectal
- Cancer: Overview of Diagnostic Procedures
- Cancer Overview
- Cancer Rehabilitation
- Cancer Treatment Protocols
- Grading and Staging of Cancer
- Immunotherapy (Biological Therapy)
- Kidney Cancer
- Penile Cancer
- Prostate Cancer
- Prostate Cancer: Clinical Trials
- Prostate Cancer: Expectant Therapy
- Prostate Cancer: Psychosocial Factors
- Prostate Cancer: Stages
- Prostate Cancer Grading
- Prostate Cancer in African-American Men
- Prostate Cancer Risk Factors
- Prostate Cancer Signs and Symptoms
- Prostate Cancer Statistics
- Prostate Problems: Diagnostic and Evaluation Procedures
- Prostate Surgery
- Radiation Oncology
- Radiation Oncology: Promising New Therapies
- Radiation Therapy
- Testicular Cancer
Clinical Services
Return to Center for Holistic Urology Overview
More on Center for Holistic Urology
- Bladder Cancer
- Blood Cancer
- Brain Cancer
- Center for Lymphoma and Myeloma
- Colon Cancer
- Early Lung Cancer Action Program
- Edward S. Harkness Eye Institute
- Esophageal Cancer
- Eye Cancer
- Gastrointestinal Cancer
- Gynecological Cancer
- Head and Neck Cancer
- Kidney Cancer
- Leukemia and Myeloproliferative Disease Center
- Liver Cancer
- Lung Cancer
- Mesothelioma
- Oncology (Cancer)
- Pancreatic and Biliary Cancer
- Pediatric Cancer
- Prostate Cancer
- Rectal Cancer
- Robert M. Ellsworth Ophthalmic Oncology Center
- Soft Tissue and Bone Cancer
- Spirit of Care Program
- Stomach Cancer
- Testicular Cancer
- Urologic Cancer
Center for Holistic Urology
The Center for Holistic Urology at NewYork-Presbyterian Hospital is the only program in the country that treats prostate cancer patients using complementary therapies. These approaches, which include nutrition, biofeedback, acupuncture, exercise therapy and herbal remedies, are used to slow the progression of cancer in patients who have not had success with traditional treatments or are preferred by patients seeking an alternative route.
Investigators here are evaluating a nutrition intervention strategy that may prove a viable option for men at high risk for recurrence of prostate cancer. The four-year study is analyzing the effects of a low-fat, high-fiber diet with soy supplementation on men who have previously undergone radical prostatectomy and whose pathological analysis indicated a high risk for recurrence.
Hospital News
- Bexxar Effective as First-Line Treatment for Non-Hodgkin's Lymphoma Patients When Used With Chemotherapy
- Cancer Treatment Is First to Directly Target Tumor Blood Supply in Patients
- Combination of Abbreviated Chemotherapy with Radioactive Monoclonal Antibody Effective in Previously Untreated Non-Hodgkin's Lymphoma More
Clinical Services
RELATED LINKS
- Radiation Oncology, NewYork-Presbyterian/Columbia
- Radiation Oncology, NewYork-Presbyterian/Weill Cornell
- Hematology/Oncology, NewYork-Presbyterian/Columbia
- Hematology and Medical Oncology, NewYork-Presbyterian/Weill Cornell
- Urology, NewYork-Presbyterian/Columbia
- Urology, NewYork-Presbyterian/Weill Cornell
- Robotic Prostate Surgery, NewYork-Presbyterian/Columbia
- Robotic Prostate Surgery, NewYork-Presbyterian/Weill Cornell
- Herbert Irving Comprehensive Cancer Center
- Weill Cornell Comprehensive Cancer Care and Blood Disorders
- Center for Holistic Urology, NewYork-Presbyterian/Columbia
